{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:47:14Z","timestamp":1793198834870,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lund University","id":[{"id":"https:\/\/ror.org\/012a77v79","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Previous studies suggest an increased risk of new-onset type 2 diabetes (T2D) following SARS-CoV-2 infection, which may be subject to detection bias from increased health care contacts among the infected. We aimed to assess the causal effect of SARS-CoV-2 infection on new-onset T2D using a test-negative design and negative control outcomes. We included all individuals aged\u2009\n                    <jats:italic>\u2265<\/jats:italic>\n                    \u200918 years registered in Sweden on 1 February 2020 without prior T2D who ordered a SARS-CoV-2 test through the Swedish healthcare service between 1 February 2020 and 28 February 2022 (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u20093,175,958). A test-negative design was applied, matching infected individuals with up to five controls based on birth year, sex, region, vaccination status, and test date. Cox proportional hazards models estimated hazard ratios (HR) and 95% confidence intervals (CI) for the association between infection and new-onset T2D. The influence of COVID-19 severity was assessed using stratified Cox regression. Negative control outcomes anaemia, chronic kidney disease, and thyroid disorder were used to evaluate detection bias. SARS-CoV-2 infection was associated with a 12% (HR 1.12, 95% CI 1.04\u20131.20) increase in T2D risk, driven by elevated incidence during weeks 1\u20134 post-infection. Increased risk was concentrated among individuals hospitalized (HR 3.60, 95% CI 2.71-4.78) or admitted to intensive care (HR 4.85, 95% CI 2.60-9.05). Negative control outcomes showed similar patterns. Our findings do not support a causal effect of SARS-CoV-2 infection on new-onset T2D. Instead, observed increases appear largely attributable to increased detection of early-phase, sub-clinical T2D cases during hospitalization or intensive care.\n                  <\/jats:p>","DOI":"10.1007\/s10654-026-01422-1","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:30:30Z","timestamp":1782469830000},"page":"959-967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SARS-CoV-2 infection as a trigger of type 2 diabetes in adults: a population-based cohort study in Sweden using a double negative control design"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4166-0561","authenticated-orcid":false,"given":"Josefine","family":"Andreasson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7101-1290","authenticated-orcid":false,"given":"Louise","family":"Bennet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1883-2000","authenticated-orcid":false,"given":"Jonas","family":"Bj\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-125X","authenticated-orcid":false,"given":"Dominik","family":"Dietler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"1422_CR1","unstructured":"World Health Organization. COVID-19 epidemiological update\u201317 May 2024. 2024."},{"issue":"7862","key":"1422_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","volume":"594","author":"Z Al-Aly","year":"2021","unstructured":"Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259\u201364.","journal-title":"Nature"},{"issue":"9","key":"1422_CR3","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/s41591-023-02521-2","volume":"29","author":"B Bowe","year":"2023","unstructured":"Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med. 2023;29(9):2347\u201357.","journal-title":"Nat Med"},{"issue":"7","key":"1422_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","volume":"379","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Rawshani A, Franzen S, Sattar N, Eliasson B, Svensson AM, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633\u201344.","journal-title":"N Engl J Med"},{"issue":"18","key":"1422_CR5","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi M, Rosengren A, Svensson A-M, Kosiborod M, Pivodic A, Gudbj\u00f6rnsdottir S, et al. Excess mortality among persons with Type 2 diabetes. N Engl J Med. 2015;373(18):1720\u201332.","journal-title":"N Engl J Med"},{"key":"1422_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112417","volume":"227","author":"E Cocking","year":"2025","unstructured":"Cocking E, Daher J, Alabbood M. New-onset diabetes mellitus post COVID-19 infection: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2025;227:112417.","journal-title":"Diabetes Res Clin Pract"},{"key":"1422_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1429848","author":"J Zhou","year":"2024","unstructured":"Zhou J, Wang Y, Xu R. Association of COVID-19 infection and the risk of new incident diabetes: a systematic review and meta-analysis. Front Endocrinol. 2024. https:\/\/doi.org\/10.3389\/fendo.2024.1429848.","journal-title":"Front Endocrinol"},{"issue":"2","key":"1422_CR8","doi-asserted-by":"publisher","first-page":"e2255965","DOI":"10.1001\/jamanetworkopen.2022.55965","volume":"6","author":"AC Kwan","year":"2023","unstructured":"Kwan AC, Ebinger JE, Botting P, Navarrette J, Claggett B, Cheng S. Association of COVID-19 vaccination with risk for incident diabetes after COVID-19 infection. JAMA Netw Open. 2023;6(2):e2255965-e.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1422_CR9","doi-asserted-by":"publisher","first-page":"e1004274","DOI":"10.1371\/journal.pmed.1004274","volume":"20","author":"X Xiong","year":"2023","unstructured":"Xiong X, Lui DTW, Chung MSH, Au ICH, Lai FTT, Wan EYF, et al. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study. PLoS Med. 2023;20(7):e1004274.","journal-title":"PLoS Med"},{"issue":"1","key":"1422_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12967-026-07717-x","volume":"24","author":"H Fang","year":"2026","unstructured":"Fang H, Wang Q. The silent epidemic within the pandemic: pathophysiology and prediction of post-COVID-19 diabetes. J Translational Med. 2026;24(1):266.","journal-title":"J Translational Med"},{"key":"1422_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104487","volume":"90","author":"JY Lu","year":"2023","unstructured":"Lu JY, Wilson J, Hou W, Fleysher R, Herold BC, Herold KC, et al. Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza. EBioMedicine. 2023;90:104487.","journal-title":"EBioMedicine"},{"issue":"4","key":"1422_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2337\/dc21-1686","volume":"45","author":"PL Wander","year":"2022","unstructured":"Wander PL, Lowy E, Beste LA, Tulloch-Palomino L, Korpak A, Peterson AC, et al. The incidence of diabetes among 2,777,768 veterans with and without recent SARS-CoV-2 infection. Diabetes Care. 2022;45(4):782\u20138.","journal-title":"Diabetes Care"},{"issue":"4","key":"1422_CR13","doi-asserted-by":"publisher","first-page":"e238866","DOI":"10.1001\/jamanetworkopen.2023.8866","volume":"6","author":"Z Naveed","year":"2023","unstructured":"Naveed Z, Vel\u00e1squez Garc\u00eda HA, Wong S, Wilton J, McKee G, Mahmood B, et al. Association of COVID-19 infection with incident diabetes. JAMA Netw Open. 2023;6(4):e238866-e.","journal-title":"JAMA Netw Open"},{"key":"1422_CR14","volume":"33","author":"JW Keck","year":"2024","unstructured":"Keck JW, Lacy ME, Bressler S, Blake I, Chukwuma U, Bruce MG. COVID-19 infection and incident diabetes in American Indian and Alaska Native people: a retrospective cohort study. Lancet Reg Health. 2024;33:100727.","journal-title":"Lancet Reg Health"},{"key":"1422_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-003052","author":"O Reges","year":"2023","unstructured":"Reges O, Test T, Hoshen M, Cicurel A, Saliba W, Greenland P, et al. Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients. BMJ Open Diabetes Res Care. 2023. https:\/\/doi.org\/10.1136\/bmjdrc-2022-003052.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"1422_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3803\/EnM.2023.1662","volume":"38","author":"JH Choi","year":"2023","unstructured":"Choi JH, Kim KM, Song K, Seo GH. Risk for newly diagnosed type 2 diabetes mellitus after COVID-19 among Korean adults: a nationwide matched cohort study. Endocrinol Metab. 2023;38(2):245\u201352.","journal-title":"Endocrinol Metab"},{"issue":"6","key":"1422_CR17","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/dom.14659","volume":"24","author":"M Birabaharan","year":"2022","unstructured":"Birabaharan M, Kaelber DC, Pettus JH, Smith DM. Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: a cohort study. Diabetes Obes Metab. 2022;24(6):1176\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"1422_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00125-022-05670-0","volume":"65","author":"W Rathmann","year":"2022","unstructured":"Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after COVID-19. Diabetologia. 2022;65(6):949\u201354.","journal-title":"Diabetologia"},{"issue":"4","key":"1422_CR19","doi-asserted-by":"publisher","first-page":"e252959","DOI":"10.1001\/jamanetworkopen.2025.2959","volume":"8","author":"LE Wee","year":"2025","unstructured":"Wee LE, Lim JT, Loy EX, Chiew CJ, Tai ES, Lim SC, et al. Risk of new-onset type 2 diabetes among vaccinated adults after omicron or delta variant SARS-CoV-2 infection. JAMA Netw Open. 2025;8(4):e252959-e.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1422_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","volume":"10","author":"Y Xie","year":"2022","unstructured":"Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311\u201321.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"1422_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","volume":"24","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659\u201367.","journal-title":"Eur J Epidemiol"},{"key":"1422_CR22","volume-title":"\u00c5rsrapport 2023 [in Swedish]","author":"The Swedish National Diabetes Register","year":"2023","unstructured":"The Swedish National Diabetes Register. \u00c5rsrapport 2023 [in Swedish]. Gothenburg: The Swedish National Diabetes Register; 2023."},{"key":"#cr-split#-1422_CR23.1","unstructured":"Statistics Sweden. Population in the country, counties and municipalities on 31 December 2023 and Population Change in 2023. 2024 [updated 2024-02-22"},{"key":"#cr-split#-1422_CR23.2","unstructured":"cited 2024 Dec 12]. Available from: https:\/\/www.scb.se\/en\/finding-statistics\/statistics-by-subject-area\/population\/population-composition\/population-statistics\/pong\/tables-and-graphs\/population-statistics---year\/population-in-the-country-counties-and-municipalities-on-31-december-2023-and-population-change-in-2023\/"},{"issue":"1","key":"1422_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00125-020-05279-1","volume":"64","author":"L Bennet","year":"2021","unstructured":"Bennet L, Udumyan R, \u00d6stgren CJ, Rolandsson O, Jansson SPO, W\u00e4ndell P. Mortality in first- and second-generation immigrants to Sweden diagnosed with type 2 diabetes: a 10 year nationwide cohort study. Diabetologia. 2021;64(1):95\u2013108.","journal-title":"Diabetologia"},{"key":"1422_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending The Cox Model","author":"T Therneau","year":"2000","unstructured":"Therneau T, Grambsch P. Modeling Survival Data: Extending The Cox Model. 2000."},{"issue":"1","key":"1422_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-19621-3","volume":"15","author":"K Schmidt-Mende","year":"2025","unstructured":"Schmidt-Mende K, Feychting M, Chen E, Louro J, Modig K. Impact of primary, specialist, and hospital care data on disease frequency estimates in older adults in Sweden. Sci Rep. 2025;15(1):32583.","journal-title":"Sci Rep"},{"issue":"8","key":"1422_CR27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S2213-8587(24)00159-1","volume":"12","author":"K Taylor","year":"2024","unstructured":"Taylor K, Eastwood S, Walker V, Cezard G, Knight R, Al Arab M, et al. Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people. Lancet Diabetes Endocrinol. 2024;12(8):558\u201368.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"1422_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12916-024-03393-0","volume":"22","author":"H Gudjonsdottir","year":"2024","unstructured":"Gudjonsdottir H, Tynelius P, Stattin NS, M\u00e9ndez DY, Lager A, Brynedal B. Undiagnosed type 2 diabetes is common - intensified screening of established risk groups is imperative in Sweden: the SDPP cohort. BMC Med. 2024;22(1):168.","journal-title":"BMC Med"},{"issue":"10","key":"1422_CR29","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.2337\/dc24-1003","volume":"47","author":"R Wong","year":"2024","unstructured":"Wong R, Hall MA, Wiggen T, Johnson SG, Huling JD, Turner LE, et al. Effect of SARS-CoV-2 infection on incident diabetes by viral variant: findings from the National COVID Cohort Collaborative (N3C). Diabetes Care. 2024;47(10):1846\u201354.","journal-title":"Diabetes Care"},{"issue":"5","key":"1422_CR30","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2337\/dc22-0670","volume":"46","author":"N Holman","year":"2023","unstructured":"Holman N, Barron E, Young B, Gregg EW, Khunti K, Valabhji J, et al. Comparative incidence of diabetes following hospital admission for COVID-19 and pneumonia: A cohort study. Diabetes Care. 2023;46(5):938\u201343.","journal-title":"Diabetes Care"},{"issue":"4","key":"1422_CR31","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117-314.","journal-title":"Kidney Int"},{"issue":"37","key":"1422_CR32","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2023;44(37):3627\u201339.","journal-title":"Eur Heart J"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01422-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-026-01422-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01422-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:52:47Z","timestamp":1790268767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-026-01422-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1422"],"URL":"https:\/\/doi.org\/10.1007\/s10654-026-01422-1","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical permission for the study was granted by the Swedish Ethical Review Authority (ref. 2020\u201306492, 2021\u2009\u2212\u200901115, 2022-01355-02, 2022-06118-02, 2024-02342-02).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was not required, as determined by the Swedish Ethical Review Authority.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}